Experts flag UK-India FTA over patent terms, access to drugs

Concerns are mounting in India over the UK-India Free Trade Agreement's potential impact on access to affordable medicines. Experts fear the deal may weaken compulsory licensing norms, a crucial safeguard allowing generic drug production during public health emergencies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/p1y7eBh
via IFTTT

Read More

Over 200 cancer day care centres to be established across India: Government

The Union Health Ministry has approved the establishment of over 200 Day Care Cancer Centres (DCCCs) across India for the financial year 2025-26, including 14 in Andhra Pradesh. These centres, prioritized based on ICMR data and state proposals, will be set up in district hospitals or other government facilities.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/roF6Idu
via IFTTT

Read More

Cipla targets $1 bn US revenue in FY27

Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics like Advair and Symbicort. The company also plans to launch peptide assets and its first biosimilar in the US by Q2 FY26.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BQEjwDN
via IFTTT

Read More

ICMR study found Covid vaccination didn't raise risk of unexplained sudden deaths among young adults: J P Nadda

An ICMR study found no link between COVID-19 vaccination and unexplained sudden deaths among young Indian adults. Instead, factors like past COVID hospitalization, family history, binge drinking, drug use, and intense physical activity were identified as key risks. Another AIIMS study confirmed heart attacks remain the leading cause of sudden deaths, with no post-pandemic pattern shift observed.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6N2r4ds
via IFTTT

Read More

Delhi govt directs all pharmaceutical shops to install CCTV cameras to regulate sale of drugs without prescriptions

Delhi government mandates CCTV installation in all pharmacies by July 2025. This aims to stop the sale of low-quality and dual-use medicines without prescriptions. The focus is on high-risk drugs often misused by minors. Regular inspections and special drives will continue. Recent checks on anti-cancer drugs showed compliance with quality standards. These measures promote accountability and ensure drug safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QZYoDGL
via IFTTT

Read More

Duty relief to boost pharma companies' access to UK drug stores

The India-UK Free Trade Agreement is set to significantly benefit India's pharma and medical device industries. Tariff reductions and streamlined regulations will drive growth. Indian companies will gain easier access to the UK market. This will boost exports, especially for generics and biosimilars. The agreement also promotes cross-border research and development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tSfPBnd
via IFTTT

Read More

7,000 steps a day may be the new magic number for better health: Lancet Study

A recent study in The Lancet Public Health reveals that walking at least 7,000 steps daily significantly reduces the risk of cardiovascular disease, cancer, type-2 diabetes, dementia, depression, and falls. Even 4,000 steps show health benefits compared to minimal activity. Researchers suggest 7,000 steps is a more achievable goal than 10,000 for improved health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O7DsMKG
via IFTTT

Read More